If you have interest in staying on top of the new drug/procedure pipeline for Parkinson's, this report is hot off the press:

America’s biopharmaceutical research companies currently are developing 37 innovative new medicines to help the estimated 10 million people worldwide who are living with Parkinson’s disease. These medicines in development – all either in clinical trials or under review by the Food and Drug Administration (FDA) – include 23 for Parkinson’s disease, 11 for related conditions and 3 diagnostics, according to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA). -



http://www.phrma.org/sites/default/f...ons-report.pdf